ValuEngine upgraded shares of Lonza Group (OTCMKTS:LZAGY) from a hold rating to a buy rating in a research report report published on Saturday.
Separately, Zacks Investment Research downgraded Lonza Group from a hold rating to a strong sell rating in a report on Tuesday, February 6th.
Lonza Group stock opened at $25.05 on Friday. Lonza Group has a one year low of $19.02 and a one year high of $29.56. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.26 and a quick ratio of 0.72.
WARNING: This piece was reported by Week Herald and is the sole property of of Week Herald. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of US & international copyright legislation. The original version of this piece can be read at https://weekherald.com/2018/04/22/lonza-group-lzagy-upgraded-to-buy-by-valuengine.html.
About Lonza Group
Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and specialty ingredients markets worldwide. The company operates through two segments, Pharma&Biotech and Specialty Ingredients. It offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to dosage forms for the pharma and consumer health, and nutrition industries.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.